To view this email as a web page, click here.

Symptom Burden High Among Survivors Years After Diagnosis

Researchers examined whether cancer or treatment type impacted the symptom burden of survivors of cancer.

Investigators assessed effects of TIB on cell number, migration, invasion, estrogen, and progesterone receptor activity and content.

IN CASE YOU MISSED IT

Can m7 FLIPI Score Predict Prognosis in Follicular Lymphoma?

A new study evaluated whether the m7-FLIPI score in patients with follicular lymphoma treated with rituximab without chemotherapy can indicate prognosis.
Read more

Liquid Test, Solid Answers

FoundationOne^®Liquid can deliver reliable answers faster than tissue testing by analyzing 70 genes and reporting on microsatellite instability high (MSI-H) status from a simple blood draw.

Read more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.